|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02120 KN HOSPITAL
Nominal 
8.500 -0.110 (-1.278%) | 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Turnover | 1,619,784 | -2.086% | 1,654,289 | 1,596,266 | 1,484,903 | 1,297,430 |
| Cost of Sales | -- | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- | -- |
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (35,062) | -18.876% | (43,221) | (9,140) | (51,514) | 1,098 | |
| Profit / (Loss) on Disposal | 2,384 | -- | (70) | 68 | 406 | (79) | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (1,464) | 34.330% | (1,089) | (6,465) | (15,927) | (6,566) | |
| Profit / (Loss) before Taxation | 69,219 | 1.644% | 68,099 | 99,182 | 15,605 | 95,704 | |
| Taxation | (32,615) | 84.248% | (17,702) | (12,250) | (26,574) | (54,831) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 17,792 | 16.957% | 15,212 | (984) | (13,252) | 3,176 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 54,396 | -17.092% | 65,610 | 85,948 | (24,221) | 44,049 | |
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 46,256 | -2.809% | 47,593 | 41,452 | 44,310 | 37,658 |
| Depreciation & Amortisation | -- | -- | 154,787 | 159,390 | 160,608 | 143,991 |
| Directors' Emoluments | -- | -- | 3,501 | 2,334 | 1,743 | 1,501 |
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Qualified |
Market Valuation Indicators
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| EPS (cts) | 76.000 | -13.636% | 88.000 | 115.000 | -32.000 | 61.000 |
| DPS (cts) | 50.000 | -- | 45.000 | 40.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | 65.789% | -- | 51.136% | 34.783% | -- | -- |
| Cash flow per share ($) | 6.115 | -- | 1.341 | 3.553 | 3.046 | 2.688 |
| NBV per share ($) | 16.416 | -- | 16.830 | 16.958 | 16.107 | 16.073 |
| Remarks: | Real time quote last updated: 27/03/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 54,396 |
| %Change | -17.092% |
| EPS / (LPS) | RMB 0.760 |
| NBV Per Share (¥) | RMB 16.416 |